12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · 6d ago
Gainers
- Innovative Eyewear (NASDAQ:LUCY) stock rose 84.4% to $4.21 during Friday's regular session. The market value of their outstanding shares is at $7.0 million.
- SS Innovations (NASDAQ:SSII) stock moved upwards by 43.27% to $6.99. The market value of their outstanding shares is at $944.7 million.
- Anbio Biotechnology (NASDAQ:NNNN) shares rose 41.89% to $16.4. The market value of their outstanding shares is at $507.3 million.
- Processa Pharmaceuticals (NASDAQ:PCSA) shares increased by 32.68% to $0.32. The company's market cap stands at $2.8 million.
- Citius Oncology (NASDAQ:CTOR) stock moved upwards by 29.67% to $2.01. The market value of their outstanding shares is at $110.9 million.
- Quantum BioPharma (NASDAQ:QNTM) shares increased by 23.92% to $37.4. The market value of their outstanding shares is at $87.7 million.
Losers
- SeaStar Medical Holding (NASDAQ:ICU) shares fell 66.7% to $0.32 during Friday's regular session. The market value of their outstanding shares is at $10.3 million.
- Moleculin Biotech (NASDAQ:MBRX) shares declined by 48.89% to $0.3. The company's market cap stands at $8.2 million.
- Regencell Bioscience (NASDAQ:RGC) shares declined by 43.12% to $36.03. The company's market cap stands at $824.3 million.
- Capricor Therapeutics (NASDAQ:CAPR) stock decreased by 22.74% to $9.22. The company's market cap stands at $545.7 million.
- Aptevo Therapeutics (NASDAQ:APVO) stock declined by 21.64% to $4.02. The company's market cap stands at $3.4 million.
- Galectin Therapeutics (NASDAQ:GALT) shares fell 21.59% to $2.58. The market value of their outstanding shares is at $208.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.